Comanagement of Diabetic Kidney Disease by the Primary Care Provider and Nephrologist

Medical Clinics of North America

Volumn 97, Issue 1, 2013, Pages 157-173

  Bowman, Brendan T ^a   Kleiner, Amanda ^a   Bolton, W Kline ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Collaborative care; Comanagement; Diabetic kidney disease; Internist

Indexed keywords

CHRONIC KIDNEY DISEASE; DIABETIC RETINOPATHY; ENDOCRINOLOGIST; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; HYPERGLYCEMIA; NEPHROLOGIST; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCREENING;

COOPERATIVE BEHAVIOR; DELIVERY OF HEALTH CARE, INTEGRATED; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DISEASE MANAGEMENT; EARLY DIAGNOSIS; HUMANS; MASS SCREENING; MODELS, ORGANIZATIONAL; NEEDS ASSESSMENT; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT CARE TEAM; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION;

EID: 84871730948     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.10.012     Document Type: Review

References (90)

1. Castro A.F., Coresh J. CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis 2009, 53(3 Suppl 3):S46-S55.
2. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007, 49(2 Suppl 2):S12-S154.
3. Collins A.J., Foley R.N., Chavers B., et al. United States Renal Data System 2011 Annual Data Report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 2012, 59(1 Suppl 1):A7. e1-420.
4. Lou Arnal L.M., Campos G.B., Cuberes I.M., et al. Nefrologia 2010, 30(5):552-556. [in Spanish].
5. Olsen S., Mogensen C.E. How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature. Diabetologia 1996, 39(12):1638-1645.
6. American Diabetes Association Standards of medical care in diabetes - 2012. Diabetes Care 2012, 35(Suppl 1):S11-S63.
7. Najafian B., Mauer M. Progression of diabetic nephropathy in type 1 diabetic patients. Diabetes Res Clin Pract 2009, 83:1-8.
8. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
9. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352(9131):854-865.
10. Yokoyama H., Araki S., Haneda M., et al. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25). Diabetologia 2012, 55(7):1911-1918.
11. Go A., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
12. Evaluate Patients with CKD. National Institutes of Health 2012. Available at: Accessed on September 13th, 2012. http://nkdep.nih.gov/identify-manage/evaluate-patients.shtml.
13. Owen W.F. Patterns of care for patients with chronic kidney disease in the United States: dying for improvement. J Am Soc Nephrol 2003, 14(7 Suppl 2):S76-S80.
14. Snyder J.J., Collins A.J. KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999-2004. Am J Nephrol 2009, 30(1):44-54.
15. Kohan D.E., Rosenberg M.E. The chronic kidney disease epidemic: a challenge for nephrology training programs. Semin Nephrol 2009, 29(5):539-547.
16. The impact of health care reform on the future supply and demand for physicians updated projections through 2025. 2012. Ref Type: Online Source.
17. Accountable Care Organizations (ACO). 4-5-0012. Centers for Medicare & Medicaid Services. Ref Type: Online Source.
18. Understanding the patient-centered medical home. 2012. American College of Physicians. Ref Type: Online Source.
19. DuBose T.D., Behrens M.T., Berns A., et al. The patient-centered medical home and nephrology. J Am Soc Nephrol 2009, 20(4):681-682.
20. Martinez-Ramirez H.R., Jalomo-Martinez B., Cortes-Sanabria L., et al. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist. Am J Kidney Dis 2006, 47(1):78-87.
21. Khan S.S., Xue J.L., Kazmi W.H., et al. Does predialysis nephrology care influence patient survival after the initiation of dialysis?. Kidney Int 2005, 67(3):1038-1046.
22. Tseng C.L., Kern E.F., Miller D.R., et al. Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease. Arch Intern Med 2008, 168(1):55-62.
23. Meyers J.L., Candrilli S.D., Kovacs B. Type 2 diabetes mellitus and renal impairment in a large outpatient electronic medical records database: rates of diagnosis and antihyperglycemic medication dose adjustment. Postgrad Med 2011, 123(3):133-143.
24. Boulware L., Troll M., Jaar B., et al. Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis 2006, 48(2):192-204.
25. Strippoli G.F., Craig J.C., Schena F.P. The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol 2004, 15(2):411-419.
26. Stoves J., Connolly J., Cheung C.K., et al. Electronic consultation as an alternative to hospital referral for patients with chronic kidney disease: a novel application for networked electronic health records to improve the accessibility and efficiency of healthcare. Qual Saf Health Care 2010, 19(5):e54.
27. Cortes-Sanabria L., Cabrera-Pivaral C.E., Cueto-Manzano A.M., et al. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial. Am J Kidney Dis 2008, 51(5):777-788.
28. Rayner H.C., Hollingworth L., Higgins R., et al. Systematic kidney disease management in a population with diabetes mellitus: turning the tide of kidney failure. BMJ Qual Saf 2011, 20(10):903-910.
29. de Boer I.H., Sun W., Cleary P.A., et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 2011, 365(25):2366-2376.
30. Moyer V.A. Screening for chronic kidney disease: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2012, 157(8):567-570.
31. Manns B., Hemmelgarn B., Tonelli M., et al. Population based screening for chronic kidney disease: cost effectiveness study. BMJ 2010, 341:c5869.
32. Ryan T.P., Sloand J.A., Winters P.C., et al. Chronic kidney disease prevalence and rate of diagnosis. Am J Med 2007, 120(11):981-986.
33. Humphreys J., Harvey G., Coleiro M., et al. A collaborative project to improve identification and management of patients with chronic kidney disease in a primary care setting in Greater Manchester. BMJ Qual Saf 2012, 21(8):700-708.
34. Fox C.H., Swanson A., Kahn L.S., et al. Improving chronic kidney disease care in primary care practices: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med 2008, 21(6):522-530.
35. Rutkowski M., Mann W., Derose S., et al. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente. Am J Kidney Dis 2009, 53(3 Suppl 3):S86-S99.
36. Campbell G.A., Bolton W.K. Referral and comanagement of the patient with CKD. Adv Chronic Kidney Dis 2011, 18(6):420-427.
37. Herget-Rosenthal S., Quellmann T., Linden C., et al. How does late nephrological co-management impact chronic kidney disease? - an observational study. Int J Clin Pract 2010, 64(13):1784-1792.
38. Ritz E. Consequences of late referral in diabetic renal disease. Acta Diabetol 2002, 39(Suppl 1):S3-S8.
39. Arora P., Obrador G.T., Ruthazer R., et al. Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol 1999, 10:1281-1286.
40. Fisher M., Ahya S., Gordon E. Interventions to reduce late referrals to nephrologists. Am J Nephrol 2011, 33:60-69.
41. Navaneethan S.D., Aloudate S., Singh S. A systematic review of patient and health system characteristics associated with late referral in CKD. BMC Nephrol 2009, 9:3.
42. Campbell K.H., Smith S.G., Hemmerich J., et al. Patient and provider determinants of nephrology referral in older adults with severe chronic kidney disease: a survey of provider decision making. BMC Nephrol 2011, 12:47.
43. Gandhi T.K., Sittig D.F., Franklin M., et al. Communication breakdown in the outpatient referral process. J Gen Intern Med 2000, 15(9):626-631.
44. Diamantidis C.J., Powe N.R., Jaar B.G., et al. Primary care-specialist collaboration in the care of patients with chronic kidney disease. Clin J Am Soc Nephrol 2011, 6(2):334-343.
45. Ronksley P.E., Hemmelgarn B.R. Optimizing care for patients with CKD. Am J Kidney Dis 2012, 60(1):133-138.
46. Bolton W.K., Owen W.F. Preparing the kidney failure patient for renal replacement therapy. Teamwork optimizes outcomes. Postgrad Med 2002, 111(6):97-108.
47. Clancy C.M. Kidney-related diseases and quality improvement: AHRQ's role. Clin J Am Soc Nephrol 2011, 6(10):2531-2533.
48. Diabetes care quality improvement: resource guide. 9-14-2012. Ref Type: Online Source. Available at: http://www.ahrq.gov/qual/diabqual/diabqguidemod5.htm.
49. Bolton W.K. Renal Physicians Association. Clinical practice guideline: appropriate patient preparation for renal replacement therapy. Guideline Number 3. Renal Physicians Association Guideline. J Am Soc Nephrol 2003, 14(5):1406-1410.
50. Bolton W.K. The role of the nephrologist in ESRD/pre-ESRD care: a collaborative approach. J Am Soc Nephrol 1998, 9:S90-S95.
51. Bolton W.K. Nephrology nurse practitioners in a collaborative care model. Am J Kidney Dis 1998, 31:786-793.
52. Holley J.L., McGuirl K. Advanced practice nurses in ESRD: varied roles and a cost analysis. Nephrol News Issues 2000, 14(3):18-20.
53. Bolton W.K., Kliger A.S. Chronic renal insufficiency: current understandings and their implications. Am J Kidney Dis 2000, 36(6):S4-S12.
54. Renders C.M., Valk G.D., Griffin S., et al. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev 2001, (1). CD001481.
55. Pimouguet C., Le G.M., Thiebaut R., et al. Effectiveness of disease-management programs for improving diabetes care: a meta-analysis. CMAJ 2011, 183(2):E115-E127.
56. Wynia M.K., Von K.I., Mitchell P.H. Challenges at the intersection of team-based and patient-centered health care: insights from an IOM working group. JAMA 2012, 308(13):1327-1328.
57. Saxena R., Bygren P., Butkowski R.J., et al. Specificity of kidney-bound antibodies in Goodpasture's syndrome. Clin Exp Immunol 1989, 78:31-36.
58. Hemmelgarn B.R., Manns B.J., Zhang J., et al. Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol 2007, 18:993-999.
59. Richards N., Whitfield M., O'Donoghue D., et al. Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes. Nephrol Dial Transplant 2008, 23(2):549-555.
60. Wu I.W., Wang S.Y., Hsu K.H., et al. Multidisciplinary predialysis education decreased the incidence of dialysis and reduces mortality-a controlled cohort study based on the NKF/DOQI guidelines. Nephrol Dial Transplant 2009, 24:3426-3433.
61. Thanamayooran S., Rose C., Hirsch D.J. Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets. Nephrol Dial Transplant 2005, 20:2385-2393.
62. Kim-Hwang J.E., Chen A.H., Bell D.S., et al. Evaluating electronic referrals for specialty care at a public hospital. J Gen Intern Med 2010, 25(10):1123-1128.
63. Chang J., Ronco C., Rosner M.H. Computerized decision support systems: improving patient safety in nephrology. Nat Rev Nephrol 2011, 7(6):348-355.
64. Abdel-Kader K., Fischer G.S., Li J., et al. Automated clinical reminders for primary care providers in the care of CKD: a small cluster-randomized controlled trial. Am J Kidney Dis 2011, 58(6):894-902.
65. O'Reilly D., Holbrook A., Blackhouse G., et al. Cost-effectiveness of a shared computerized decision support system for diabetes linked to electronic medical records. J Am Med Inform Assoc 2012, 19(3):341-345.
66. UKPDS 3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998, 352(9131):837-853.
67. Ohkubo Y., Kishikawa H., Araki E., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1901, 28(2):103-117. [see comments].
68. Shichiri M., Kishikawa H., Ohkubo Y., et al. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000, 23(Suppl 2):B21-B29.
69. Coppelli A., Giannarelli R., Vistoli F., et al. The beneficial effects of pancreas transplant alone on diabetic nephropathy. Diabetes Care 2005, 28(6):1366-1370.
70. Gross J.L., de Azevedo M.J., Silveiro S.P., et al. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005, 28(1):164-176.
71. American Diabetes Association. Nephropathy in Diabetes. Position Statement. Diab Care 2004, 27:S79-S83.
72. Grant R.W., Buse J.B., Meigs J.B. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care 2005, 28(2):337-442.
73. Quinn D.C., Graber A.L., Elasy T.A., et al. Overcoming turf battles: developing a pragmatic, collaborative model to improve glycemic control in patients with diabetes. Jt Comm J Qual Improv 2001, 27(5):255-264.
74. Del P.S., Felton A.M., Munro N., et al. Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Recommendations from the Global Partnership for Effective Diabetes Management. Int J Clin Pract Suppl 2007, 157:47-57.
75. Cramer J.A. A systematic review of adherence with medications for diabetes. Diabetes Care 2004, 27(5):1218-1224.
76. Odegard P.S., Gray S.L. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ 2008, 34(4):692-697.
77. Phillips L.S., Branch W.T., Cook C.B., et al. Clinical inertia. Ann Intern Med 2001, 135(9):825-834.
78. Shah B.R., Hux J.E., Laupacis A., et al. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?. Diabetes Care 2005, 28(3):600-606.
79. Phillips L.S., Ziemer D.C., Doyle J.P., et al. An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site: improving primary care of African Americans with diabetes (IPCAAD) 7. Diabetes Care 2005, 28(10):2352-2360.
80. de Sonnaville J.J., Bouma M., Colly L.P., et al. Sustained good glycaemic control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study. Diabetologia 1997, 40(11):1334-1340.
81. Verlato G., Muggeo M., Bonora E., et al. Attending the diabetes center is associated with increased 5-year survival probability of diabetic patients: the Verona Diabetes Study. Diabetes Care 1996, 19(3):211-213.
82. Graber A.L., Elasy T.A., Quinn D., et al. Improving glycemic control in adults with diabetes mellitus: shared responsibility in primary care practices. South Med J 2002, 95(7):684-690.
83. Hardy K., Furlong N., Hulme S., et al. Delivering improved management and outcomes in diabetic kidney disease in routine clinical care. Br J Diabetes Vasc Dis 2007, 7:172-182.
84. Gerich J.E., Meyer C., Woerle H.J., et al. Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 2001, 24(2):382-391.
85. Valera Mora M.E., Scarfone A., Calvani M., et al. Insulin clearance in obesity. J Am Coll Nutr 2003, 22(6):487-493.
86. Mak R.H., DeFronzo R.A. Glucose and insulin metabolism in uremia. Nephron 1992, 61(4):377-382.
87. Becker B., Kronenberg F., Kielstein J.T., et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 2005, 16(4):1091-1098.
88. Hajjar S.M., Fadda G.Z., Thanakitcharu P., et al. Reduced activity of Na(+)-K+ ATPase of pancreatic islets in chronic renal failure: role of secondary hyperparathyroidism. J Am Soc Nephrol 1992, 2(8):1355-1359.
89. Chagnac A., Weinstein T., Zevin D., et al. Effects of erythropoietin on glucose tolerance in hemodialysis patients. Clin Nephrol 1994, 42(6):398-400.
90. Runyan J.W., Hurwitz D., Robbins S.L. Effect of Kimmelstiel-Wilson syndrome on insulin requirements in diabetes. N Engl J Med 1955, 252(10):388-391.